Pinnacle Associates Ltd. Purchases 53 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pinnacle Associates Ltd. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% during the 3rd quarter, Holdings Channel reports. The firm owned 2,552 shares of the medical equipment provider’s stock after acquiring an additional 53 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Intuitive Surgical were worth $1,254,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ISRG. First Trust Direct Indexing L.P. boosted its position in Intuitive Surgical by 8.6% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 13,483 shares of the medical equipment provider’s stock valued at $6,624,000 after acquiring an additional 1,066 shares in the last quarter. Evermay Wealth Management LLC boosted its position in Intuitive Surgical by 32.6% during the 3rd quarter. Evermay Wealth Management LLC now owns 427 shares of the medical equipment provider’s stock valued at $210,000 after acquiring an additional 105 shares in the last quarter. Creekmur Asset Management LLC boosted its position in Intuitive Surgical by 288.7% during the 3rd quarter. Creekmur Asset Management LLC now owns 1,854 shares of the medical equipment provider’s stock valued at $911,000 after acquiring an additional 1,377 shares in the last quarter. Adell Harriman & Carpenter Inc. boosted its position in Intuitive Surgical by 13.3% during the 3rd quarter. Adell Harriman & Carpenter Inc. now owns 680 shares of the medical equipment provider’s stock valued at $334,000 after acquiring an additional 80 shares in the last quarter. Finally, Childress Capital Advisors LLC boosted its position in Intuitive Surgical by 1.8% during the 3rd quarter. Childress Capital Advisors LLC now owns 1,607 shares of the medical equipment provider’s stock valued at $789,000 after acquiring an additional 28 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $506.34 on Friday. The business has a fifty day moving average of $490.41 and a 200 day moving average of $446.60. The firm has a market capitalization of $180.35 billion, a price-to-earnings ratio of 81.41, a price-to-earnings-growth ratio of 5.05 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $269.49 and a 1 year high of $523.34.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Mizuho increased their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Truist Financial increased their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.